LYRA
Price
$7.95
Change
-$0.19 (-2.33%)
Updated
Jul 25 closing price
Capitalization
12.71M
16 days until earnings call
ROQAF
Price
$0.02
Change
-$0.03 (-60.00%)
Updated
Jul 14 closing price
Capitalization
2.99M
Interact to see
Advertisement

LYRA vs ROQAF

Header iconLYRA vs ROQAF Comparison
Open Charts LYRA vs ROQAFBanner chart's image
Lyra Therapeutics
Price$7.95
Change-$0.19 (-2.33%)
Volume$13.82K
Capitalization12.71M
Roquefort Therapeutics
Price$0.02
Change-$0.03 (-60.00%)
Volume$1K
Capitalization2.99M
LYRA vs ROQAF Comparison Chart in %
Loading...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYRA vs. ROQAF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRA is a Hold and ROQAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (LYRA: $7.95 vs. ROQAF: $0.02)
Brand notoriety: LYRA and ROQAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYRA: 2% vs. ROQAF: 145%
Market capitalization -- LYRA: $12.71M vs. ROQAF: $2.99M
LYRA [@Biotechnology] is valued at $12.71M. ROQAF’s [@Biotechnology] market capitalization is $2.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYRA’s FA Score shows that 0 FA rating(s) are green whileROQAF’s FA Score has 1 green FA rating(s).

  • LYRA’s FA Score: 0 green, 5 red.
  • ROQAF’s FA Score: 1 green, 4 red.
According to our system of comparison, LYRA is a better buy in the long-term than ROQAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYRA’s TA Score shows that 4 TA indicator(s) are bullish while ROQAF’s TA Score has 0 bullish TA indicator(s).

  • LYRA’s TA Score: 4 bullish, 4 bearish.
  • ROQAF’s TA Score: 0 bullish, 4 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than ROQAF.

Price Growth

LYRA (@Biotechnology) experienced а +0.63% price change this week, while ROQAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

LYRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LYRA($12.7M) has a higher market cap than ROQAF($2.99M). LYRA YTD gains are higher at: -22.965 vs. ROQAF (-57.300).
LYRAROQAFLYRA / ROQAF
Capitalization12.7M2.99M424%
EBITDA-44.7MN/A-
Gain YTD-22.965-57.30040%
P/E RatioN/AN/A-
Revenue1.19MN/A-
Total Cash31.7MN/A-
Total Debt33.4MN/A-
TECHNICAL ANALYSIS
Technical Analysis
LYRAROQAF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
33%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
20%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GBIO4.610.41
+9.76%
Generation Bio Co
SVC3.030.14
+4.84%
Service Properties Trust
THG166.993.77
+2.31%
Hanover Insurance Group (The)
CMG46.761.02
+2.23%
Chipotle Mexican Grill
JMSB19.110.23
+1.22%
John Marshall Bancorp

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-2.33%
ROQAF - LYRA
85%
Closely correlated
N/A
EYPT - LYRA
58%
Loosely correlated
-0.10%
KYMR - LYRA
54%
Loosely correlated
-0.13%
VERA - LYRA
54%
Loosely correlated
-0.32%
BPMC - LYRA
42%
Loosely correlated
N/A
More

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been closely correlated with LYRA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if ROQAF jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
LYRA - ROQAF
85%
Closely correlated
-2.33%
EYPT - ROQAF
37%
Loosely correlated
-0.10%
RIGL - ROQAF
22%
Poorly correlated
-1.27%
RYTM - ROQAF
21%
Poorly correlated
-0.94%
OKYO - ROQAF
3%
Poorly correlated
-0.36%
More